« Return to News | CROs/Service Providers

ICON's Earnings Up, Sales Down

Thursday, October 22, 2009 06:09 AM

Dublin-based ICON, a global contract research organization (CRO), reported third quarter net income jumped 12% on sales that fell 2.3% to $220.3 million, compared with the year ago quarter.

Year-to-date, net revenues were $660.2 million, up 2.3% compared with the same period last year.

Income from operations increased by 12% to $30.4 million, compared with $27.1 million for the same quarter last year.Net income for the quarter was $24 million, compared with $21.4 million last year. Earnings per share jumped 14% to 40 cents per share on a diluted basis.

“Despite the economic and industry headwinds,” said ICON's CEO Peter Gray,  “ICON has continued to improve margins, grow earnings and significantly improve cash flows enabling us to again raise earnings guidance for 2009. While higher than normal cancellations held back net business awards, the levels of business opportunity continue to be strong and we remain optimistic for the future.”

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.